dr. vogelzang on cabozantinib clinical trial results
Published 13 years ago • 325 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:35
dr. vogelzang discusses cabozantinib trial design
-
1:34
dr. vogelzang discusses the cabozantinib trial design
-
1:45
dr. vogelzang discusses cabozantinib's dose size
-
1:14
dr. vogelzang describes cabozantinib's side effects
-
2:22
nicholas vogelzang, md, discusses re-emergence of dose reduced cabozantinib alezotuzumab in apc
-
1:11
dr. vogelzang on xl184's effect on bone metastases
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
6:00
clinical rationale for cabozantinib in hcc
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:34
dr. vogelzang discusses prospect trial for prostate cancer
-
7:08
final analysis of the atlantis cabozantinib comparison
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:55
dr. chan on trial of cabozantinib in neuroendocrine tumors
-
6:30
cabozantinib: the meteor trial
-
7:17
cabozantinib in renal cell carcinoma
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc